Shire focusing on integration in near term

Shire plc (LSE:SHP; NASDAQ:SHPG) CEO Flemming Ornskov said the company is on track to complete its acquisition of Baxalta Inc. (NYSE:BXLT) mid-year, and plans to focus in the near term on integration of Baxalta and hereditary angioedema (HAE) play Dyax Corp. The comments came on a conference call Thursday to discuss Shire's 4Q15 and 2015 financial results.

"We are a company that constantly looks both at tuck-ins on the product side and will continue to do that, and we also look at M&A," noted Ornskov. "But I think the focus right now is on the integration." ...